Cargando…

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers

SIMPLE SUMMARY: Fecal occult blood tests (FOBTs) detect colorectal cancer (CRC) at high levels of sensitivity and specificity. However, the detection of early-stage cancers is highly important to reduce CRC mortality. We aimed to assess the sensitivity of a large number of different FOBTs according...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gies, Anton, Niedermaier, Tobias, Gruner, Laura Fiona, Heisser, Thomas, Schrotz-King, Petra, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914536/ https://www.ncbi.nlm.nih.gov/pubmed/33562775 http://dx.doi.org/10.3390/cancers13040644

Ejemplares similares

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
por: Niedermaier, Tobias, et al.
Publicado: (2018)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
por: Gruner, Laura F., et al.
Publicado: (2021)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Variation of Positive Predictive Values of Fecal Immunochemical Tests by Polygenic Risk Score in a Large Screening Cohort
por: Niedermaier, Tobias, et al.
Publicado: (2022)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Assessment of a Serum Microrna Risk Score for Colorectal Cancer among Participants of Screening Colonoscopy at Various Stages of Colorectal Carcinogenesis
por: Raut, Janhavi R., et al.
Publicado: (2022)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial
por: Gruner, Laura Fiona, et al.
Publicado: (2020)

Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review
por: Zhao, Zitong, et al.
Publicado: (2021)

Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review
por: Raut, Janhavi R., et al.
Publicado: (2020)

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

Comparing Metabolomics Profiles in Various Types of Liquid Biopsies among Screening Participants with and without Advanced Colorectal Neoplasms
por: Erben, Vanessa, et al.
Publicado: (2021)

Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Risk Factors of Inadequate Bowel Preparation for Screening Colonoscopy
por: Amitay, Efrat L., et al.
Publicado: (2021)

Reusing a prepaid health plan’s fecal immunochemical tests for microbiome associations with colorectal adenoma
por: Goedert, James J., et al.
Publicado: (2022)

Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2021)

Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for Hemoglobin
por: Suehiro, Yutaka, et al.
Publicado: (2020)

Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Immunochemical Fecal Occult Blood Test for Detection of Advanced Colonic Adenomas and Colorectal Cancer: Comparison with Colonoscopy Results
por: Viana Freitas, Bianca Rosa, et al.
Publicado: (2013)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart
por: Bhardwaj, Megha, et al.
Publicado: (2022)

Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study
por: Wu, Dong, et al.
Publicado: (2014)

Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
por: Brenner, Hermann, et al.
Publicado: (2018)

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
por: Erben, Vanessa, et al.
Publicado: (2018)

Correction to: Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas
por: Chen, Hong-Da, et al.
Publicado: (2021)

Cell Line Secretome and Tumor Tissue Proteome Markers for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Whole-blood DNA Methylation Markers for Risk Stratification in Colorectal Cancer Screening: A Systematic Review
por: Raut, Janhavi R., et al.
Publicado: (2019)

Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT
por: Mosen, David M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vifr1sp3e93n8v97a8kb45nlfg